Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROMIPLOSTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROMIPLOSTIM: Safety Overview

Metric ROLAPITANT ROMIPLOSTIM
Total FAERS Reports 873 7,510
Deaths Reported 252 865
Death Rate 28.9% 11.5%
Hospitalizations 155 1,812
Average Patient Age 61.4 yrs 56.7 yrs
% Female Patients 57.5% 55.7%
FDA Approval Date Oct 25, 2017 N/A
Manufacturer TerSera Therapeutics LLC Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription